To investigate how GPBAR1 affects NAFLD after SG, GPBAR1 inhibitor Triamterene (72 mg/kg) was given to NAFLD mice after SG surgery. The gene discussed is GPBAR1; the disease is metabolic dysfunction-associated steatotic liver disease.